Accuracy of a Newly Developed Mobile Application Versus the Conventional Method of Cephalometric Analysis in the Diagnosis of Dental and Skeletal Deformities Among Pre-adolescent Patients

Accuracy of a Newly Developed Mobile Application Versus the Conventional Method of Cephalometric Analysis in the Diagnosis of Dental and Skeletal Deformities Among Pre-adolescent Patients: A Diagnostic Accuracy Study

This study aims to evaluate the accuracy of a newly developed mobile application versus the conventional method of cephalometric analysis in the diagnosis of dental and skeletal deformities among pre-adolescent patients.

Study Overview

• Status: Not yet recruiting
• Conditions: Mobile Application; Cephalometric Analysis
• Intervention / Treatment: Diagnostic test: newly developed mobile application

Detailed Description

A mobile application will be developed to help pedodontists in orthodontic diagnosis, and treatment of dentoalveolar, or skeletal deformations ,The mobile application will provide quick cephalometric analysis and therefore, offers rapid and accurate case diagnosis, reduces errors in tracing, measurement, and identification of the landmark.

Reference test: Cephalometric analysis by the conventional method

-Trial design: Diagnostic accuracy study

• Study Type: Interventional
• Enrollment (Anticipated): 17
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 8 years to 13 years (Child)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Digital Lateral cephalometric radiographs of pre-adolescent patients (8-13) years old.
2. Cephalogram of good quality with all landmarks clearly visible
3. Presence of central incisors and first molars on cephalogram
4. Cephalogram with teeth in maximum intercuspation

Exclusion Criteria:

-

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Lateral cephalometric radiographs of pre-adolescent patients (8-13) years old.

Diagnostic test: newly developed mobile application; The application will be developed in native Android, using Java (backend) and XML (front-end) as the programming language. The program of choice will be Android Studio®, YouTube® (video reproduction) and Firebase® (database) will be used as external APIs (Application Programming Interfaces). The layout of the application will be developed using: Adobe Illustrator® software. The logo, brand, objects, and shapes of the mobile application will be designed to enable to resize of the images without any loss of quality, due to the wide range of scales available in current smartphones

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The Accuracy of the newly developed mobile application versus the conventional method of cephalometric analysis in the diagnosis	The accuracy of the mobile application will be measured based on cephalometric analysis angles( by degrees) of Egyptian people according to Soliman SA. PHD thesis 1988	3 monthes

Collaborators and Investigators

• Sponsor: Cairo University

Study record dates

Study Major Dates

• Study Start (Anticipated): December 1, 2021
• Primary Completion (Anticipated): November 1, 2022
• Study Completion (Anticipated): December 1, 2022

Study Registration Dates

• First Submitted: September 14, 2021
• First Submitted That Met QC Criteria: October 6, 2021
• First Posted (Actual): October 7, 2021

Study Record Updates

• Last Update Posted (Actual): October 7, 2021
• Last Update Submitted That Met QC Criteria: October 6, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Congenital Abnormalities
• Other Study ID Numbers: mobile app in ceph.analysis

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No